{
    "2015-06-09": [
        "Trading in Regeneron halted pending Ad Comm news later today #premarket $REGN $SNY",
        "#FDA Roberts: Changes in glucose/homeostasis are monitorable & treatable #EMDAC #Praluent #PCSK9 $SNY $REGN",
        "ICYMI: Repatha review not quite Praluent mirror; dosing stands out $AMGN $SNY $REGN #FDA #Repatha #Praluent #EMDAC",
        "$SNY is rated BUY, 7.5% upside by Wall Street analysts based on average ratings/targets"
    ]
}